SCHEMBL6513858

SCHEMBL6513858

COC(=O)[C@H](CC(C)C)Nc1nc(Cl)cc(Nc2cccc(C#N)c2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 2/20 0.42
NPR3 P17342 3/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
ABCG2 Q9UNQ0 2/20 0.41
SYK P43405 1/20 0.40
SLK Q9H2G2 3/20 0.39
STK10 O94804 2/20 0.39
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
PTGES O14684 3/20 0.37
ALOX5 P09917 3/20 0.37
PPARG P37231 2/20 0.37
PPARA Q07869 2/20 0.37
ELANE P08246 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
RXRA P19793 1/20 0.37
RXRG P48443 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6513867 1.00 SLC2A1 (0.42) SLC2A1NPR3CYP2C9CYP2C19ABCG2
SCHEMBL6510872 0.86 NPR3 (0.44) SLC2A1NPR3CYP2C9CYP2C19ABCG2
SCHEMBL6510875 0.86 NPR3 (0.44) SLC2A1NPR3CYP2C9CYP2C19ABCG2
SCHEMBL6508232 0.77 NPR3 (0.60) NPR3CYP2C9CYP2C19ELANE
SCHEMBL6508225 0.77 NPR3 (0.60) NPR3CYP2C9CYP2C19ELANE
SCHEMBL6517243 0.76 MAPT (0.43) SLC2A1ABCG2SMN1; SMN2PTGESALOX5
SCHEMBL6530469 0.72 NPR3 (0.55) NPR3CYP2C9CYP2C19ELANE
SCHEMBL6530463 0.72 NPR3 (0.55) NPR3CYP2C9CYP2C19ELANE
SCHEMBL6507731 0.71 CYP2C9 (0.43) SLC2A1NPR3CYP2C9CYP2C19SMN1; SMN2
SCHEMBL6507727 0.71 CYP2C9 (0.43) SLC2A1NPR3CYP2C9CYP2C19SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO disclosed
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO disclosed